Physician profile
Nicholas E Alexander
NPI 1841044526
$479.75
in general payments reported to CMS, 2019-2025
17 companies · $283 in 2025
The $283 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $197 · 2025: $283.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $480.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $479.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $60.68 | 2025 | Repatha, Otezla, Evenity |
| Glaxosmithkline, LLC. | $52.17 | 2024-2025 | Trelegy Ellipta, Shingrix |
| Axsome Therapeutics, INC. | $48.16 | 2024-2025 | Auvelity |
| Lilly USA, LLC | $46.83 | 2024-2025 | Mounjaro, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.33 | 2024-2025 | Jardiance |
| Otsuka America Pharmaceutical, INC. | $36.72 | 2025 | Rexulti |
| Abbvie INC. | $34.94 | 2024-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.82 | 2025 | Xifaxan |
| Lundbeck LLC | $20.35 | 2024 | Rexulti |
| Pfizer INC. | $16.25 | 2025 | |
| Corium, LLC | $15.80 | 2025 | Azstarys |
| Astellas Pharma US INC | $15.63 | 2024 | Veozah |
| Paratek Pharmaceuticals, INC. | $14.82 | 2024 | Nuzyra |
| Exact Sciences Corporation | $14.66 | 2024 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $14.59 | 2024 | Farxiga |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $13.82 | 2025 | Jornay Pm |
| Phathom Pharmaceuticals, INC. | $13.18 | 2024 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Alexander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.